From: The silent struggle: assessing anxiety prevalence in Marrakech’s hypertensive population
Ìý | Total participants n (%) | Self-reported anxiety n = 348 | No self-reported anxiety n = 705 |
---|---|---|---|
Comorbidity | Ìý | Ìý | Ìý |
 Y±ð²õ | 508 (48.2) | 186 (53.5) | 322 (45.7) |
 N´Ç | 545 (51.8) | 162 (46.5) | 383 (54.3) |
Diabetes | Ìý | Ìý | Ìý |
 Y±ð²õ | 458 (43.5) | 169 (48.6) | 289 (41.0) |
 N´Ç | 595 (56.5) | 179 (51.4) | 416 (59.0) |
Dyslipidemia | Ìý | Ìý | Ìý |
 Y±ð²õ | 56 (05.3) | 22 (06.3) | 34 (04.8) |
 N´Ç | 997 (94.7) | 326 (93.7) | 671 (95.2) |
Duration of hypertension | Ìý | Ìý | Ìý |
 More than five years | 499 (47.4) | 181 (52.0) | 318 (45.1) |
 Less than or equal to five years | 554 (52.6) | 167 (48.0) | 387 (54.9) |
Family history of hypertension | Ìý | Ìý | Ìý |
 Y±ð²õ | 601 (57.1) | 248 (71.3) | 353 (50.0) |
 N´Ç | 452 (42.9) | 100 (28.7) | 352 (50.0) |
Controlled blood pressure | Ìý | Ìý | Ìý |
 N´Ç | 749 (71.1) | 256 (73.6) | 493 (69.9) |
 Y±ð²õ | 304 (28.9) | 92 (26.4) | 212 (30.1) |
Autonomy | Ìý | Ìý | Ìý |
 Y±ð²õ | 79 (07.5) | 37 (10.6) | 42 (06.0) |
 N´Ç | 974 (92.5) | 311 (89.4) | 663 (94.0) |
Reduced mobility | Ìý | Ìý | Ìý |
 Y±ð²õ | 126 (12.0) | 64 (18.4) | 62 (08.8) |
 N´Ç | 927 (88.0) | 284 (81.6) | 643 (91.2) |
Pain and physical discomfort | Ìý | Ìý | Ìý |
 Y±ð²õ | 587 (55.8) | 240 (69.0) | 347 (49.2) |
 N´Ç | 466 (44.2) | 108 (31.0) | 358 (50.8) |
Overweight or obesity | Ìý | Ìý | Ìý |
 Y±ð²õ | 843 (80.1) | 296 (85.1) | 547 (77.6) |
 N´Ç | 210 (19.9) | 52 (14.9) | 158 (22.4) |